Mustang Non Current Liabilities Total vs Total Current Assets Analysis
MBIO Stock | USD 0.22 0.02 8.33% |
Mustang Bio financial indicator trend analysis is infinitely more than just investigating Mustang Bio recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mustang Bio is a good investment. Please check the relationship between Mustang Bio Non Current Liabilities Total and its Total Current Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
Non Current Liabilities Total vs Total Current Assets
Non Current Liabilities Total vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mustang Bio Non Current Liabilities Total account and Total Current Assets. At this time, the significance of the direction appears to have weak relationship.
The correlation between Mustang Bio's Non Current Liabilities Total and Total Current Assets is 0.3. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Mustang Bio, assuming nothing else is changed. The correlation between historical values of Mustang Bio's Non Current Liabilities Total and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Mustang Bio are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Non Current Liabilities Total i.e., Mustang Bio's Non Current Liabilities Total and Total Current Assets go up and down completely randomly.
Correlation Coefficient | 0.3 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Non Current Liabilities Total
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Most indicators from Mustang Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mustang Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.As of the 24th of May 2024, Selling General Administrative is likely to drop to about 9 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 155.8 K
Mustang Bio fundamental ratios Correlations
Click cells to compare fundamentals
Mustang Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mustang Bio fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Other Current Liab | 236K | 3.8M | 9.2M | (270K) | 8.3M | 8.7M | |
Total Current Liabilities | 7.8M | 9.5M | 10.8M | 15.1M | 15.4M | 9.2M | |
Total Stockholder Equity | 51.7M | 98.4M | 112.4M | 46.3M | 123K | 116.9K | |
Net Tangible Assets | 36.4M | 51.7M | 98.4M | 112.4M | 129.3M | 135.7M | |
Net Debt | (45.9M) | (95.6M) | (107.6M) | (44.3M) | (3.7M) | (3.9M) | |
Retained Earnings | (125.5M) | (185.5M) | (251.8M) | (329.4M) | (381.0M) | (361.9M) | |
Accounts Payable | 2.5M | 9.2M | 10.5M | 14.5M | 6.3M | 6.5M | |
Common Stock Shares Outstanding | 2.4M | 3.5M | 5.9M | 6.9M | 8.6M | 5.3M | |
Non Current Liabilities Total | 14.0M | 2.0M | 2.0M | 31.0M | 2.2M | 2.1M | |
Capital Surpluse | 98.7M | 113.4M | 172.2M | 276.0M | 317.4M | 333.2M | |
Other Stockholder Equity | 172.2M | 276.0M | 359.9M | 374.5M | 380.5M | 223.5M | |
Total Liab | 21.8M | 11.5M | 12.8M | 46.1M | 17.6M | 15.5M | |
Total Assets | 73.4M | 109.9M | 125.2M | 92.4M | 17.7M | 16.9M | |
Cash | 61.4M | 97.8M | 109.6M | 75.7M | 6.2M | 5.9M | |
Non Current Assets Total | 10.4M | 10.4M | 13.5M | 13.6M | 6.4M | 8.8M | |
Other Assets | 771K | 1.3M | 2.8M | 1.4M | 1.6M | 1.3M | |
Cash And Short Term Investments | 61.4M | 97.8M | 109.6M | 75.7M | 6.2M | 5.9M | |
Retained Earnings Total Equity | (48.4M) | (79.1M) | (125.5M) | (185.5M) | (166.9M) | (158.6M) | |
Liabilities And Stockholders Equity | 73.4M | 109.9M | 125.2M | 92.4M | 17.7M | 16.9M | |
Total Current Assets | 63.1M | 99.5M | 111.7M | 78.9M | 11.3M | 10.8M | |
Accumulated Other Comprehensive Income | 4.9M | 7.9M | 4.3M | 1.1M | 591K | 561.5K | |
Property Plant Equipment | 9.1M | 9.1M | 12.1M | 12.3M | 14.2M | 8.0M | |
Property Plant And Equipment Net | 9.1M | 9.1M | 12.1M | 12.3M | 4.8M | 8.8M | |
Net Receivables | 19K | 15K | 50K | 36K | 3.9M | 4.1M | |
Other Current Assets | 1.6M | 1.7M | 2.0M | 3.2M | 1.2M | 1.7M | |
Net Invested Capital | 65.1M | 98.4M | 112.4M | 73.7M | 123K | 116.9K | |
Property Plant And Equipment Gross | 9.1M | 9.1M | 12.1M | 12.3M | 9.3M | 9.5M | |
Net Working Capital | 55.3M | 90.0M | 100.9M | 63.7M | (4.0M) | (3.8M) | |
Capital Stock | 4K | 7K | 9K | 11K | 1K | 950.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Mustang Stock analysis
When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.40) | Revenue Per Share (0) | Return On Assets (0.56) | Return On Equity (3.22) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.